First Light Acquisition Group (FLAG) Adds $25M to Calidi Biotherapeutics Deal
First Light (FLAG) announced this morning that it has secured $25 million in additional funding for its combination with clinical-stage drug developer Calidi Biotherapeutics.
The investment is to be led by Jackson Investment Group, which has put forward $5 million as the first stage of a Series B. ...READ MORE
